The House Appropriations Subcommittee on Ag/FDA approved its appropriations bill for funding the Food and Drug Administration (FDA) for Fiscal Year (FY) 2018. The House will be in recess next week so it is unclear when the full Appropriations Committee may act.
The bill reported out by the subcommittee would give the FDA $2.76 billion in appropriated dollars for FY 18. This is the same level of funding as FY 17 and $870 million more than the administration’s budget request. In addition, the committee appropriated $60 million to carry out selected activities under the “21st Century Cures Act,” which became law in December 2016. The bill also includes $2.3 billion in expected user fees, an increase of $400 million. This amount is consistent with user fee reauthorization legislation now moving through Congress. As a reminder, more than 80% of the FDA’s budget is dedicated to its personnel needs.
While the American public would benefit with even a higher level of resources for FDA, I am very pleased the subcommittee rejected the cuts to appropriations asked for by the administration. Congress is showing bipartisan recognition of the important work NTEU members at the FDA perform.
As of today, Congress has not announced the timing for consideration of appropriations at other bureaus of the Department of Health & Human Services.
NTEU will continue to be a voice for our members at HHS as this process moves forward.